Findings define a connection between reward, dopamine, and circadian pathways in the overeating.
Astrocytes hijack microglia for the benefit of tumor growth in medulloblastoma, causing the microglia to produce IGF1. The findings could aid in the development of new treatments for a range of cancers.
Upstream reciprocity, or generosity, can be seen in children as young as four years of age. At age three, 80% of children do not want to share, but at age four, 60% of children are happy to share with others.
Study identifies AIM1 inflammasomes as crucial players in the development of a properly formed central nervous system by removing genetically compromised cells. The findings shed light on neurodevelopmental dysfunctions which occur and give rise to behavioral related disorders.
Focused ultrasound treatments show promise in the fight against glioblastoma brain cancer. Sonodynamic therapy may also help treat other difficult-to-treat cancers.
An oncogene believed to be responsible for glioblastoma brain cancer has been identified. AVIL, a gene that normally helps cells to maintain their shape and size, can shift into overdrive, causing cancer cells to form and spread. Blocking the gene's activity completely destroyed glioblastoma cancer cells in mouse models, but did not have any effect on healthy cells. The findings provide potential new treatment avenues for the deadly brain cancer.
Microglia keep the Toxoplasma gondii parasite in check in the brain. Microglia release an immune molecule that recruit immune cells from the blood to control the parasite.
A new small scale study reveals the antidepressant fluvoxamine may be a new tool in the fight against COVID-19. Researchers report fluvoxamine reduced the severity of coronavirus symptoms and hospitalizations.
TEPP-46, a drug developed for the treatment of cancer and showed promise for the treatment of multiple sclerosis, could make MS symptoms worse, a new study reports. The drug appears to redirect inflammation away from the spinal cord and directly into the brain.
A baby's first breath triggers a signaling system in the brainstem that helps support early breathing. The findings shed light on how problems with this neuropeptide system can increase the risk of SIDS.
Non-invasive focused ultrasound appears to be beneficial in the treatment of Parkinson's disease for patients whose symptoms are poorly controlled by traditional medications.